DocGo Inc. (DCGO) Form 10-Q — Nov 9, 2026
DocGo's Q3 2026 10-Q shows a shrinking business: nine-month revenue fell 10% to $222.4M and net loss was $53.0M, with Mobile Health revenue down sharply to $65.2M from $96.7M as municipal migrant-related contracts ended. Q3 itself showed a slight revenue uptick to $73.4M and a narrower loss of $18.3M versus $29.7M a year ago, helped by prior-year impairments not recurring. The most serious disclosure is liquidity and going concern. As of September 30, 2026 the company had only $19.1M of unrestricted cash and working capital of $30.1M, was out of compliance with its minimum liquidity covenant at December 31, 2025, and says it will need to burn cash while management plans cost cuts.
Key figures
- Revenue
- 222406408
- Revenue Yoy
- -10.1% (nine months: $222.4M vs $247.3M)
- Total Assets
- 173900854
- Cash Position
- 19107209
- Shares Outstanding
- 98992347
- Q3 revenue
- 73431205
- Q3 revenue yoy
- +3.7% (Q3: $73.4M vs $70.8M)
- Working capital
- 30054566
- Delayed draw term loan
- 25000000
- Goodwill impairment fy2025
- 58228096
- Allowance for credit losses
- 8428825
- Intangible impairment fy2025
- 22627902
- Revolving facility available
- 55000000
- Perceptive credit agreement term loans
- 77000000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.